IPO Review: Supriya Lifescience Ltd
Moneylife Digital Team 15 December 2021
Supriya Lifescience manufactures active pharmaceutical ingredients (APIs) in domestic and international markets. Established in 1987 SLL offers 38 APIs focused on therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. It has been the largest exporter of Chlorpheniramine Maleate (CPM) and Ketamine Hydrochloride from India, contributing...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback